Position in LQDA
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$112,400,085
+$60,800,637 QoQ
Shares Held
1,409,759
+3.1% QoQ
Ownership
1.57%
of shares outstanding
% of Portfolio
2.95%
of 13F equity value
Holder Rank
#12
of 333 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Caprock Group, LLC holds $122,719,355 across 16 Drug Manufacturers - Specialty & Generic names. LQDA ranks #1 (91.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
This page
|
1,409,759 | $112,400,085 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
77,986 | $2,642,165 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
55,602 | $1,368,365 | |
| 4 | VTRS |
Viatris Inc
|
75,955 | $1,206,165 | |
| 5 | ZTS |
Zoetis Inc.
|
13,819 | $993,033 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
40,725 | $652,821 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
3,295 | $555,339 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
32,404 | $469,533 |
All Filings in LQDA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $112,400,085 | 1,409,759 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $51,599,448 | 1,367,235 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $61,527,435 | 1,783,921 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $37,113,703 | 1,632,089 | Shares | Sole | 2025-11-06 | |
| No filing history on record for this holder in this stock. | ||||||